Biocom Appoints Additional Members to Board of Directors

SAN DIEGO–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/Biocom?src=hash" target="_blank"gt;#Biocomlt;/agt;–Biocom, the association representing the California life science
industry, today announced that it has added Matt Abernethy, chief
financial officer of Neurocrine Biosciences, and Sabrina Martucci
Johnson, president and chief executive officer of Daré Biosciences, to
its board of directors.

“Mr. Abernethy’s in-depth knowledge in healthcare finance coupled with
Ms. Johnson’s extensive experience as a life science executive, will
provide the Biocom board with new insights and perspectives as we
continue to develop innovative programs that support the diverse needs
of our members throughout the state,” said Joe Panetta, president and
CEO of Biocom. “Mr. Abernethy and Ms. Johnson represent two sectors on
the frontier of innovation within the life science industry—neuroscience
and women’s healthcare, respectively—and will be instrumental as members
of our board.”

Mr. Abernethy was appointed chief financial officer of Neurocrine in
November 2017 and is responsible for leading corporate finance
activities and commercial supply chain operations, as well as
information technology and investor relations functions. Mr. Abernethy
has over 15 years of experience in the financial sector and investor
relations with expertise in the healthcare industry.

Ms. Johnson founded Daré Bioscience Operations Inc. in 2015 and has
served as president, chief executive officer and a member of the board
of directors since its inception and following its business combination
with Cerulean Pharma Inc., when the company was renamed Daré Bioscience.
Previously, Ms. Johnson held multiple titles at WomanCare Global
Trading, a specialty pharmaceutical company in female reproductive
healthcare with commercial product distribution in over 100 countries,
including president, chief financial officer, chief operating officer
and before that served as chief financial and chief operating officer at
Cypress Bioscience.

About Biocom

Biocom is the largest, most experienced leader and advocate for
California’s life science sector. We work on behalf of more than 1,100
members to drive public
policy, build an enviable network
of industry leaders, create access
to capital, introduce cutting-edge
STEM education programs, and create robust value-driven purchasing
programs.

Founded in 1995 in San Diego, Biocom provides the strongest public voice
to research institutions and companies that fuel the local and
state-wide economy. Our goal is simple: to help our members produce
novel solutions that improve the human condition. In addition to our San
Diego headquarters, Biocom operates core offices in Los
Angeles and the San
Francisco Bay Area, satellite offices in Washington,
D.C. and Tokyo,
and has a continuous staff presence in Sacramento. Our broad membership
benefits apply to biotechnology, pharmaceutical, medical device,
genomics and diagnostics companies of all sizes, as well as to research
universities and institutes, clinical research organizations, investors
and service providers.

For more information on Biocom, please visit our website at www.biocom.org.
Connect with us on LinkedIn, Facebook,
and Twitter (@BIOCOMCA).

Contacts

Biocom Media Contact:
Carolyn Hawley
Canale
Communications
(619) 849-5382
[email protected]